COMPARISON OF PROLACTIN RESPONSES TO D-1 AND D-2 ANTAGONISTS IN RATS - RO-22-1319 IS A POTENT D-2 ANTAGONIST

被引：3

作者：

KANEDA, H

SHINTANI, T

KAKIGI, T

TERADA, T

TANIMOTO, K

机构：

来源：

BIOLOGICAL PSYCHIATRY | 1989年 / 25卷 / 04期

关键词：

D O I：

10.1016/0006-3223(89)90210-2

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：517 / 522

页数：6

共 11 条

[1]

[Anonymous], FRONT NEUROENDOCRIN

[2] INTERACTION OF SCH-23390, A D-1-SELECTIVE ANTAGONIST, WITH THE ANTERIOR-PITUITARY D-2 RECEPTORS AND PROLACTIN SECRETION IN THE RAT [J].

APUD, JA ;

MASOTTO, C ;

ONGINI, E ;

RACAGNI, G .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (02) :187-193

[3]

BAUTZ G, 1981, SOC NEUR ABSTR, V7, P866

[4] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].

CREESE, I ;

BURT, DR ;

SNYDER, SH .

SCIENCE, 1976, 192 (4238) :481-483

[5] PHARMACOLOGICAL EFFECTS OF RO-22-1319 - A NEW ANTI-PSYCHOTIC AGENT [J].

DAVIDSON, AB ;

BOFF, E ;

MACNEIL, DA ;

WENGER, J ;

COOK, L .

PSYCHOPHARMACOLOGY, 1983, 79 (01) :32-39

[6] SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST [J].

HYTTEL, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) :153-154

[7]

IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462

[8] MULTIPLE RECEPTORS FOR DOPAMINE [J].

KEBABIAN, JW ;

CALNE, DB .

NATURE, 1979, 277 (5692) :93-96

[9]

NAKAJIMA T, 1984, MOL PHARMACOL, V26, P430

[10] ANTIPSYCHOTIC DRUG DOSES AND NEUROLEPTIC-DOPAMINE RECEPTORS [J].

SEEMAN, P ;

LEE, T ;

CHAUWONG, M ;

WONG, K .

NATURE, 1976, 261 (5562) :717-719

← 1 2 →